Loading...

Landec Corporation

LNDC•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$8.76
$-0.32(-3.52%)

Landec Corporation (LNDC) Stock Overview

Explore Landec Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.7/100

Key Financials

Market Cap263.6M
P/E Ratio21.08
EPS (TTM)$-2.17
ROE2.28%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$7.86

LNDC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Landec Corporation (LNDC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $7.86.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 21.08 and a market capitalization of 263.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;